Search results

Filters
Close
ADDED DATE
Added date
TOPICS Please select
WATCH / LISTEN / READ TIME
Medical Options for Advanced HFpEF/HFmrEF Patients: Patient Cases
Author(s): Muthiah Vaduganathan , Added: 1 year ago
Part one of this programme explores two interactive case studies on advanced treatment options for HFpEF and HFmrEF from Prof Pardeep Jhund (University of Glasgow, UK) and Dr Muthiah Vaduganathan (Brigham and Women’s Hospital and Harvard Medical School, US). We encourage you to submit your answers on treatment options in the provided polls.These results will support part two of the programme, An… View more

Heart Failure
Decoding the Future of HF — Key Takeaways from 2024
Author(s): Muthiah Vaduganathan , Orly Vardeny , Added: 1 year ago
Recorded at American Heart Association 2024 in Chicago, Dr Muthiah Vaduganathan (Brigham and Women’s Hospital and Harvard Medical School, Boston, US), Dr Orly Vardeny (University of Minnesota Medical School, Minneapolis, US) and Prof Pardeep Jhund (University of Glasgow, Glasgow, UK) explore cardiometabolic disease in heart failure with mid-range or preserved ejection fraction (HFmrEF and HFpEF)… View more

Heart Failure
HFSA 2025 Late-Breaking Science Collection
Author(s): Nir Uriel Added: 6 months ago
Discover the latest heart failure data from impactful trials and studies presented at the Heart Failure Society of America's annual congress, HFSA 2025.For quick and practical summaries of the late-breaking trials, watch our 5-minute Expert Interviews conducted with the investigators. View more

Cardiovascular Kidney Metabolic

Guidelines & Statements
ESC HF 2025 Late-Breaking Science Collection
Author(s): Jasper J Brugts Added: 11 months ago
Watch our video collection following the late-breaking science sessions from the ESC Heart Failure Association's 2025 congress. Our Expert Interviews provide insights on the hottest data and key take-home messages from the most influential trials. View more

MI/ACS

Prevention & Chronic Conditions
A Spotlight on SGLT2 Initiation in HF Hospitalisation
Author(s): Clara Saldarriaga , David Berg Added: 7 months ago
This webinar series, recorded at the ESC 2025 with key opinion leaders Dr David Berg (Brigham and Women's Hospital, Boston, US) and Dr Clara Saldarriaga (Cardio VID Clinic, Medellin, CO) presenting late-breaking data, explores the evolving evidence for in-hospital initiation of guideline-directed medical therapy after an acute heart failure event. Viewers will gain insight into the persistent… View more

Heart Failure
Breakthrough Mineralocorticoid Receptor Agonists in Cardiovascular Care
Author(s): Javed Butler , Dinesh Khullar , John JV McMurray , et al Added: 4 months ago
In this expert-led webinar moderated by Dr Vijay Chopra, leading clinicians review current and emerging strategies in aldosterone modulation, hyperkalaemia management, and cardiorenal therapeutics.Dr Javed Butler opens with a practical overview of aldosterone’s central role in heart failure and CKD, emphasising the importance of achieving guideline-directed RAAS inhibitor and MRA dosing. He… View more

Prevention & Chronic Conditions

Heart Failure
ESC 2025 Hot Line & Late-Breaking Collection
Author(s): Joost Daemen , Nicolas M Van Mieghem Added: 8 months ago
Dive into our coverage of ESC Congress 2025 for groundbreaking trial results and discussions with expert faculty.Watch ourView From the Thoraxcenterseries for practice-focused reviews of the most anticipated trials from interventional experts,Prof Nicolas Van MieghemandDr Joost Daemen. Watch our Wrap-Upseries led byDr Mirvat Alasnag summarising the key take-aways from each day of the congress.For… View more

Imaging & Diagnostics

Intervention
Optimising RAASi Management in Cardiorenal Patients: An Expert Roundtable
Author(s): Andrew Frankel , Shelley Zieroth , Aaron Wong , et al Added: 1 year ago
In this on-demand version of the live roundtable, cardiologists Dr Shelley Zieroth (University of Manitoba, Winnipeg, CA) and Dr Aaron Wong (Princess of Wales Hospital, Wales, UK) join nephrologists Dr Andrew Frankel (Imperial College Healthcare NHS Trust, London, UK), and Dr Manish Sood (University of Ottawa, CA) to discuss the nuanced landscape of RAASi management in cardiorenal patients.In… View more

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
Hyperkalaemia in the Cardiorenal Patient - Navigating Guidelines & Real-World Data
Author(s): Clara Bonanad Lozano , Anjay Rastogi Added: 1 year ago
Dr Anjay Rastogi (David Geffen School of Medicine UCLA, US) and Dr Clara Bonanad (University Clinical Hospital of Valencia, ES) discuss the evolving management strategies of hyperkalaemia in heart failure and chronic kidney disease, in this short video series. In this three part discussion they cover the most recent guidelines from ACC, ESC and KDIGO, real-world evidence from the recent ZORA… View more

Prevention & Chronic Conditions

Cardiovascular Kidney Metabolic
Mulatero P, Cardiovasc Hematol Ag Med Chem 2006
Author(s): James Burton , Aaron Wong Added: 10 months ago
Watch these two brief patient case studies and take a moment to answer a short poll for each one.Your responses will help shape a practical discussion focused on supporting clinical decision-making in real-world settings.As part of our expert-led programme, Managing Hyperkalaemia: Getting Patients to Optimal RAASi Therapy, taking place on 02 July 2025, the Faculty will explore current trends in… View more

Prevention & Chronic Conditions